News

Most investors buy sector-specific mutual funds or exchange-traded funds for investment reasons—because they think a sector ...
One technology firm, one REIT, and a utility that’s a dividend aristocrat. David Harrell: Hi, I’m David Harrell, editor of ...
The view that the Fed will quickly cut rates stems from how late the Fed was in starting its fight against inflation in 2022, Harris said. Fed Chair Jerome Powell argued for months that inflation was ...
Most Americans say they have changed their spending habits or expect to do so.
At the group level, we do not believe New World Development possesses an economic moat, particularly for its property development and investment in Hong Kong and mainland China. We forecast NWD to ...
Despite rising bond yields, Goldman Sachs is sticking to its 6500 target for the S&P 500 SPX 12 months out.
President Trump said tariffs on imported steel would go to 50% from 25%. That has investors excited early Monday. Andrew Witty, who largely led the U.S. healthcare giant from the U.K., made big bets ...
Global stocks and U.S. futures started the new month lower after Trump threatened to double tariffs on steel and aluminum, and trade tensions escalated between China and the U.S. The Chinese Commerce ...
Hailey Bieber has landed a spot in the coveted billionaire's club after she signed a $1 billion deal for e.l.f Beauty to acquire her skin care and makeup brand, Rhode-a deal that will see her taking ...
The Chicago suburb where Pope Leo XIV grew up has taken steps to acquire his humble childhood home before the property can be sold off to the highest bidder at a planned auction. Pope Leo, who was ...
Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare arm ...
The deal includes a drug for systemic mastocytosis, a rare immunology disease, approved in the U.S. and the European Union under the brand names Ayvakit and Ayvakyt as well as an early-stage ...